Quarterly report pursuant to Section 13 or 15(d)

License Agreement (Details Narrative)

v3.25.0.1
License Agreement (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
May 31, 2021
May 31, 2020
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Jun. 30, 2024
May 04, 2021
Research and development expense     $ 1,220,535 $ 1,062,672 $ 2,535,394 $ 2,332,892    
Preferred stock, par value     $ 0.001   $ 0.001   $ 0.001 $ 0.001
Vernalis Development Limited [Member]                
Research and development expense   $ 150,000            
Development milestone payment   29,900,000            
Vernalis Development Limited [Member] | IPO [Member]                
Number of shares of common stock 192,857              
Preferred stock, par value $ 0.001              
Future milestone payments $ 1,400,000              
Vernalis Development Limited [Member] | Minimum [Member]                
Marketing authorization amount   400,000            
Sales milestone payments   10,000,000.0            
Cumulative annual net sales amount   500,000,000.0            
Vernalis Development Limited [Member] | Maximum [Member]                
Marketing authorization amount   3,000,000.0            
Sales milestone payments   25,000,000.0            
Cumulative annual net sales amount   $ 1,000,000,000.0